• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流感疫苗短缺政策的系统分析

A systematic analysis of influenza vaccine shortage policies.

作者信息

Uscher-Pines Lori, Barnett Daniel J, Sapsin Jason W, Bishai David M, Balicer Ran D

机构信息

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Suite 492, Baltimore, MD 21205, USA.

出版信息

Public Health. 2008 Feb;122(2):183-91. doi: 10.1016/j.puhe.2007.06.005. Epub 2007 Sep 7.

DOI:10.1016/j.puhe.2007.06.005
PMID:17825858
Abstract

OBJECTIVES

The aim of this study was to apply SWOT analysis (strengths, weaknesses, opportunities, threats) to a domestic shortage of influenza vaccine, to identify lessons learned, and to generate effective solutions for future public health rationing emergencies.

STUDY DESIGN/METHODS: SWOT and TOWS techniques were employed to characterize the vulnerability of the USA to disruptions in the supply of influenza vaccine. A group of five researchers reviewed relevant literature, engaged in group brainstorming, and categorized elements according to the SWOT framework.

RESULTS

Three strengths, five weaknesses, five threats and seven opportunities were identified in the areas of vaccine production, purchasing and distribution, and provision. Four future recommendations emerged with respect to government investment, communications, sanctioning of physicians, and incident command.

CONCLUSIONS

Application of the SWOT technique is highly relevant to the health policy realm and can assist public health planners in planning for future resource scarcity.

摘要

目的

本研究旨在对国内流感疫苗短缺情况进行SWOT分析(优势、劣势、机会、威胁),总结经验教训,并为未来公共卫生配给紧急情况制定有效解决方案。

研究设计/方法:采用SWOT和TOWS技术来描述美国在流感疫苗供应中断方面的脆弱性。一组五名研究人员查阅了相关文献,进行了小组头脑风暴,并根据SWOT框架对各项因素进行了分类。

结果

在疫苗生产、采购与分发以及供应领域,确定了三项优势、五项劣势、五项威胁和七项机会。在政府投资、沟通、对医生的制裁以及事件指挥方面提出了四项未来建议。

结论

SWOT技术的应用与卫生政策领域高度相关,可协助公共卫生规划人员应对未来资源短缺情况。

相似文献

1
A systematic analysis of influenza vaccine shortage policies.流感疫苗短缺政策的系统分析
Public Health. 2008 Feb;122(2):183-91. doi: 10.1016/j.puhe.2007.06.005. Epub 2007 Sep 7.
2
Ethics and public health emergencies: rationing vaccines.伦理与突发公共卫生事件:疫苗分配
Am J Bioeth. 2006 Nov-Dec;6(6):4-7. doi: 10.1080/15265160601021256.
3
When the cat is out of the bag: a case study in public health rationing in Oregon during the 2004-2005 influenza vaccine shortage.秘密泄露之时:2004 - 2005年流感疫苗短缺期间俄勒冈州公共卫生配给的案例研究
J Public Health Manag Pract. 2008 Sep-Oct;14(5):464-70. doi: 10.1097/01.PHH.0000333881.45270.97.
4
Community planning for pandemic influenza: lessons from the VA health care system.大流行性流感的社区规划:来自退伍军人事务部医疗保健系统的经验教训。
Disaster Med Public Health Prep. 2008 Dec;2(4):251-7. doi: 10.1097/DMP.0b013e31817dd143.
5
Impact of a severe influenza vaccine shortage on primary care practice.严重流感疫苗短缺对基层医疗实践的影响。
Am J Prev Med. 2007 Dec;33(6):486-91. doi: 10.1016/j.amepre.2007.07.038.
6
Lessons learned: role of influenza vaccine production, distribution, supply, and demand--what it means for the provider.经验教训:流感疫苗生产、分发、供应及需求的作用——对提供者意味着什么。
Am J Med. 2008 Jul;121(7 Suppl 2):S22-7. doi: 10.1016/j.amjmed.2008.05.004.
7
Pandemic influenza vaccine: determining vaccination priorities.大流行性流感疫苗:确定疫苗接种优先次序
RN. 2008 Oct;71(10):30-2; quiz 35.
8
Potential population-based electronic data sources for rapid pandemic influenza vaccine adverse event detection: a survey of health plans.用于快速检测大流行性流感疫苗不良事件的基于人群的潜在电子数据源:健康计划调查
Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1137-41. doi: 10.1002/pds.1642.
9
Model-based drug development: strengths, weaknesses, opportunities, and threats for broad application of pharmacometrics in drug development.基于模型的药物研发:药物研发中广泛应用药物代谢动力学的优势、劣势、机遇和挑战。
J Clin Pharmacol. 2010 Sep;50(9 Suppl):31S-46S. doi: 10.1177/0091270010377629.
10
[Influenza vaccine: globalization of public health stakes].[流感疫苗:公共卫生利益的全球化]
Med Trop (Mars). 2009 Aug;69(4):322.

引用本文的文献

1
Synthetic biology-inspired development of live attenuated influenza vaccines.受合成生物学启发的减毒活流感疫苗研发。
NPJ Vaccines. 2025 Aug 27;10(1):204. doi: 10.1038/s41541-025-01255-1.
2
Replication of Vectored Herpesvirus of Turkey (HVT) in a Continuous, Microcarrier-Independent Suspension Cell Line from Muscovy Duck.火鸡载体疱疹病毒(HVT)在源自番鸭的连续、不依赖微载体的悬浮细胞系中的复制
Vaccines (Basel). 2025 Jun 30;13(7):714. doi: 10.3390/vaccines13070714.
3
An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic.
在 COVID-19 大流行期间发展中国家公平分配流感疫苗的库存-位置优化模型。
Vaccine. 2021 Jan 15;39(3):495-504. doi: 10.1016/j.vaccine.2020.12.022. Epub 2020 Dec 9.
4
Prioritising access to pandemic influenza vaccine: a review of the ethics literature.优先获得大流行性流感疫苗:对伦理文献的回顾。
BMC Med Ethics. 2020 May 14;21(1):40. doi: 10.1186/s12910-020-00477-3.
5
Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets.活减 H1N1 流感疫苗候选物在小鼠和雪貂中显示出强大的效力。
PLoS One. 2019 Oct 14;14(10):e0223784. doi: 10.1371/journal.pone.0223784. eCollection 2019.
6
A Review of DNA Vaccines Against Influenza.抗流感DNA疫苗综述。
Front Immunol. 2018 Jul 9;9:1568. doi: 10.3389/fimmu.2018.01568. eCollection 2018.
7
Analyzing and strengthening the vaccine safety program in Manitoba.分析并加强曼尼托巴省的疫苗安全计划。
Can Commun Dis Rep. 2014 Dec 4;40(Suppl 3):31-36. doi: 10.14745/ccdr.v40is3a04.
8
Nanorobot Hardware Architecture for Medical Defense.用于医疗防御的纳米机器人硬件架构。
Sensors (Basel). 2008 May 6;8(5):2932-2958. doi: 10.3390/s8052932.
9
Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.改良安卡拉痘苗病毒生产工艺开发中的要素
Microorganisms. 2013 Nov 1;1(1):100-121. doi: 10.3390/microorganisms1010100.
10
Matrix and backstage: cellular substrates for viral vaccines.基质与后台:病毒疫苗的细胞底物
Viruses. 2014 Apr 11;6(4):1672-700. doi: 10.3390/v6041672.